Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

• Main Authors: Maria Kamusheva (Author), Manoela Manova (Author), Alexandra T. Savova (Author), Guenka I. Petrova (Author), Konstantin Mitov (Author), András Harsányi (Author), Zoltán Kaló (Author), Kristóf Márky (Author), Pawel Kawalec (Author), Bistra Angelovska (Author), Dragana Lakić (Author), Tomas Tesar (Author), Pero Draganic (Author), Mary Geitona (Author), Magdalini Hatzikou (Author), Marian S. Paveliu (Author), Agnes Männik (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2018-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objectives: The aim of the study was to compare the access of patients with rare diseases (RDs) to biotechnological drugs in several Central and Eastern European countries (CEECs). We focused on the legislative pricing and reimbursement requirements, availability of biotechnological orphan medicinal...